Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Cresset releases Flare V12 to cut synthesis and testing cycles with faster, more flexible FEP

Cresset has released Flare V12, a new version of its computer-aided drug design (CADD) solution for the discovery, design and optimization of small molecules. Flare V12 is focussed on improving access to Free Energy Perturbation (FEP) in drug discovery.

FEP is used to predict how strongly drug candidates bind to their targets, helping guide compound selection. However, despite its recognised accuracy, adoption has often been limited by computational cost, usability barriers and challenges in modeling complex chemical transformations.

Cambridge Stock Exchange Project and JP Jenkins announce Strategic Partnership.

Here's some  exciting news about the Cambridge Stock Exchange Project (CSEP).

The Cambridge Stock Exchange Project is creating a platform for accessing liquidity from the market inside high-density innovation ecosystems across the UK. 

You can also learn more about the initiative on the Cambridge Stock Exchange Project website.

Research / Senior Scientist

We’re looking for a technically capable and reliable Senior/Research Scientist to join our Discovery Team at Sortera Bio. This is a lab-based role focused on the operation of our proprietary Deep Screening technology, and provision of broader support for library preparation, NGS, and hit validation workflows.

Senior Scientist - Compound Profiling

At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No.

Live Q&A - Ask the Experts: From Preclinical to First-in-Human

Transitioning from preclinical development into first-in-human is one of the most critical and complex stages in drug development. Early strategic decisions can have a significant impact on timelines, regulatory interactions, study success, and overall programme progression.

Join Dr Jon Sisson, Executive Medical Director, Clinical Development and Regulatory Strategy, and Christopher Floyd, SVP, Head of Clinical and Medical and Head of Neuroscience, as they answer your questions and share practical insights on the key considerations for successful early clinical development.

Head of Science and Technology Strategy

About the Wellcome Genome Campus

WGCL is the owner, operator and developer of the Wellcome Genome Campus, which is located nine miles south of Cambridge, within an established life science cluster and ecosystem. WGCL and the Campus are owned by a world-renowned endowment fund that is committed to expanding its existing campus into a global centre for genomics, biodata sciences and associated technologies.

Bionow BioInsight Conference 2026

BioInsight: Exploring Ideas, Enabling Impact

BioInsight is a new conference by Bionow which brings together the life sciences community of Scotland and beyond to share insights, technological and business developments and forge valuable new connections.

With a focus on translating and commercialising new technologies, BioInsight will explore the trends, technologies and collaborations shaping the future of the sector.

Research Associate (Fixed Term)

Applications are invited for an enthusiastic and motivated Research Associate to join the Laboratory of David Owen and Bernard Kelly at the Cambridge Institute for Medical Research. Our work combines cell biology, structural biology and biochemistry/biophysics to build a deep, integrated understanding of intracellular trafficking mechanisms, with a particular emphasis on cargo sorting in the endocytic system. The successful candidate will study the cell biology of receptor trafficking between the plasma membrane and endosomes.

Subscribe to